Contact
Please use this form to send email to PR contact of this press release:
Chi-Med Initiates a Phase II Trial of Surufatinib in Combination with Tuoyi in Patients with Advanced Solid Tumors
TO:
Please use this form to send email to PR contact of this press release:
Chi-Med Initiates a Phase II Trial of Surufatinib in Combination with Tuoyi in Patients with Advanced Solid Tumors
TO: